TOI Health News Morning Briefing | AstraZeneca withdraws COVID vaccine, West Nile fever outbreak, pregnancy guide for summer season, fitness tips and more

[ AstraZeneca withdraws COVID vaccine worldwideAstraZeneca, the British pharmaceutical firm, is presently pulling its COVID vaccine from global circulation. This action follows months after the company acknowledged, for the first time in court records, the potential for a rare and hazardous side effect associated with the vaccine. The withdrawal request was submitted on March 5 … Read more

World Asthma Day: 7 diseases linked to Asthma

[ World Asthma Day serves as an important reminder of the global impact of asthma and the health risks associated with it. While asthma itself is a prevalent respiratory condition characterised by inflammation and narrowing of the airways, it generally coexists with other diseases, exacerbating symptoms and complicating management. Here are seven diseases that are … Read more

Drugmaker will cap inhaler costs at $35 per month amid scrutiny

[ Drugmaker Boehringer Ingelheim plans to cap the out-of-pocket costs for all its inhalers at $35 per month after coming under fire from Democratic lawmakers over pricing.  The company announced Thursday that the program will start June 1. It’s aimed at patients with employer-sponsored insurance, and those who are underinsured and uninsured, meaning they likely … Read more

A dispute over a common asthma drug leaves patients caught in the middle

[ The most common asthma inhaler for children was discontinued at the start of this year, forcing parents and pediatricians to scramble to switch to an alternative.   But more than a month later, the situation has not improved, and families remain caught in the middle of a fight between a drug company and pharmacy benefit … Read more

Baldwin calls on drug companies to stop gaming patents for asthma inhalers

[ Sen. Tammy Baldwin (D-Wis.) is demanding the four largest manufacturers of inhalers to stop improperly listing patents in a Food and Drug Administration (FDA) database, a practice that can delay lower-cost generics from coming to market.  In letters sent Monday to AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline (GSK) and Teva, Baldwin called on the companies to … Read more

Sanders, Democrats launch investigation into asthma inhaler pricing

[ Sen. Bernie Sanders (I-Vt.) and a group of Senate Democrats on Monday announced an investigation into the high costs of asthma inhalers. Sanders, chairman of the Senate Health, Education, Labor and Pensions (HELP) Committee, sent letters to the CEOs of the four biggest manufacturers of inhalers sold in the United States — AstraZeneca, Boehringer … Read more